- 7 Publicações
- 1 fotos
- 0 Vídeos
- Female
- 07/11/2001
- Seguido por 0 pessoas
© 2026 La Lingua Nostra
Portuguese (Brazil)
Atualizações recentes
- Calcium Channel Blocker Market Analysis 2032 | Regional Insights
According to a newly published market research report by 24LifeSciences, global calcium channel blocker market was valued at USD 71.5 million in 2024 and is projected to reach USD 80.4 million by 2031, growing at a compound annual growth rate (CAGR) of 1.7% during the forecast period 2025–2031.
Calcium Channel Blockers (CCBs) are a vital class of prescription medications primarily used to manage hypertension (high blood pressure), angina (chest pain), and certain cardiac arrhythmias. These drugs function by inhibiting the influx of calcium ions into cardiac and vascular smooth muscle cells, resulting in the relaxation of blood vessels. This vasodilation reduces peripheral vascular resistance and decreases blood pressure, while also increasing the supply of blood and oxygen to the heart, thereby reducing its workload. The primary types of CCBs include Dihydropyridines (e.g., Amlodipine), Diltiazem, and Verapamil, each with distinct pharmacological profiles and clinical applications.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7487/calcium-channel-blocker-marketCalcium Channel Blocker Market Analysis 2032 | Regional Insights According to a newly published market research report by 24LifeSciences, global calcium channel blocker market was valued at USD 71.5 million in 2024 and is projected to reach USD 80.4 million by 2031, growing at a compound annual growth rate (CAGR) of 1.7% during the forecast period 2025–2031. Calcium Channel Blockers (CCBs) are a vital class of prescription medications primarily used to manage hypertension (high blood pressure), angina (chest pain), and certain cardiac arrhythmias. These drugs function by inhibiting the influx of calcium ions into cardiac and vascular smooth muscle cells, resulting in the relaxation of blood vessels. This vasodilation reduces peripheral vascular resistance and decreases blood pressure, while also increasing the supply of blood and oxygen to the heart, thereby reducing its workload. The primary types of CCBs include Dihydropyridines (e.g., Amlodipine), Diltiazem, and Verapamil, each with distinct pharmacological profiles and clinical applications. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7487/calcium-channel-blocker-market0 Comentários 0 Compartilhamentos 20 Visualizações 0 AnteriorFaça o login para curtir, compartilhar e comentar! - Global Ileostomy Products Market Forecast 2025: Revenue Insights
According to a newly published market research report by 24LifeSciences, global ileostomy products market was valued at USD 767 million in 2024 and is projected to reach USD 1077 million by 2031, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period 2025–2031.
Ileostomy products are essential medical devices for individuals who have undergone ileostomy surgery, a procedure that creates a stoma (opening) in the abdominal wall to divert waste from the small intestine. These products include pouching systems, skin barriers, seals, and accessories designed to manage effluent, protect peristomal skin, and significantly improve patient quality of life. The increasing prevalence of conditions requiring bowel diversion, coupled with technological innovations in product design, is driving substantial market growth.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6755/ileostomy-products-market-marketGlobal Ileostomy Products Market Forecast 2025: Revenue Insights According to a newly published market research report by 24LifeSciences, global ileostomy products market was valued at USD 767 million in 2024 and is projected to reach USD 1077 million by 2031, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period 2025–2031. Ileostomy products are essential medical devices for individuals who have undergone ileostomy surgery, a procedure that creates a stoma (opening) in the abdominal wall to divert waste from the small intestine. These products include pouching systems, skin barriers, seals, and accessories designed to manage effluent, protect peristomal skin, and significantly improve patient quality of life. The increasing prevalence of conditions requiring bowel diversion, coupled with technological innovations in product design, is driving substantial market growth. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6755/ileostomy-products-market-market0 Comentários 0 Compartilhamentos 18 Visualizações 0 Anterior - Benchtop Sterilizers Market Size & Share Analysis 2032: Key Trends
According to a newly published market research report by 24LifeSciences, global benchtop sterilizers market was valued at USD 835 million in 2024 and is projected to reach USD 1,165 million by 2032, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 20252032.
Benchtop sterilizers are compact, self-contained devices essential for decontaminating medical and dental instruments, laboratory glassware, and various small items directly at the point of use in settings like clinics, dental offices, and research laboratories. These units employ various sterilization methods, with moist heat (steam) sterilization equipment dominating the market due to its proven efficacy, speed, and reliability for heat-stable materials. Their critical role in maintaining stringent infection control protocols underpins their importance across healthcare and life sciences sectors.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11182/benchtop-sterilizers-marketBenchtop Sterilizers Market Size & Share Analysis 2032: Key Trends According to a newly published market research report by 24LifeSciences, global benchtop sterilizers market was valued at USD 835 million in 2024 and is projected to reach USD 1,165 million by 2032, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 20252032. Benchtop sterilizers are compact, self-contained devices essential for decontaminating medical and dental instruments, laboratory glassware, and various small items directly at the point of use in settings like clinics, dental offices, and research laboratories. These units employ various sterilization methods, with moist heat (steam) sterilization equipment dominating the market due to its proven efficacy, speed, and reliability for heat-stable materials. Their critical role in maintaining stringent infection control protocols underpins their importance across healthcare and life sciences sectors. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11182/benchtop-sterilizers-market0 Comentários 0 Compartilhamentos 30 Visualizações 0 Anterior - What Is the Future of the Microplate Reader Market? 2025–2032 Outlook
According to a newly published market research report by 24LifeSciences, the global microplate reader market was valued at USD 650 million in 2024 and is projected to reach USD 892 million by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2025–2031.
Microplate readers, also known as plate readers, are laboratory instruments designed to detect biological, chemical, or physical events in samples stored in microtiter plates. They are indispensable tools for high-throughput screening, enabling the rapid analysis of multiple samples simultaneously. These instruments are critical for applications including drug discovery, bioassay validation, quality control, and basic academic research across the pharmaceutical, biotechnological, and life sciences sectors.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1939/microplate-reader-market-market-marketWhat Is the Future of the Microplate Reader Market? 2025–2032 Outlook According to a newly published market research report by 24LifeSciences, the global microplate reader market was valued at USD 650 million in 2024 and is projected to reach USD 892 million by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2025–2031. Microplate readers, also known as plate readers, are laboratory instruments designed to detect biological, chemical, or physical events in samples stored in microtiter plates. They are indispensable tools for high-throughput screening, enabling the rapid analysis of multiple samples simultaneously. These instruments are critical for applications including drug discovery, bioassay validation, quality control, and basic academic research across the pharmaceutical, biotechnological, and life sciences sectors. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1939/microplate-reader-market-market-market0 Comentários 0 Compartilhamentos 17 Visualizações 0 Anterior - Global Vinca Alkaloid Compounds Market Forecast 2025: Revenue Insights
According to a newly published market research report by 24LifeSciences, global vinca alkaloid compounds market was valued at USD 103 million in 2024 and is projected to reach USD 170 million by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2032.
Vinca alkaloid compounds are a class of naturally derived bioactive molecules extracted from the Catharanthus roseus plant, historically known as the Madagascar periwinkle. These nitrogen-containing secondary metabolites exhibit potent pharmacological properties, with established efficacy as microtubule-targeting agents that disrupt cancer cell division through spindle formation inhibition. The primary therapeutic compounds in this categoryvinblastine, vincristine, vindesine, and vinorelbineform the cornerstone of numerous chemotherapy regimens, particularly for hematological malignancies and solid tumors.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2133/vinca-alkaloid-compounds-marketGlobal Vinca Alkaloid Compounds Market Forecast 2025: Revenue Insights According to a newly published market research report by 24LifeSciences, global vinca alkaloid compounds market was valued at USD 103 million in 2024 and is projected to reach USD 170 million by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2032. Vinca alkaloid compounds are a class of naturally derived bioactive molecules extracted from the Catharanthus roseus plant, historically known as the Madagascar periwinkle. These nitrogen-containing secondary metabolites exhibit potent pharmacological properties, with established efficacy as microtubule-targeting agents that disrupt cancer cell division through spindle formation inhibition. The primary therapeutic compounds in this categoryvinblastine, vincristine, vindesine, and vinorelbineform the cornerstone of numerous chemotherapy regimens, particularly for hematological malignancies and solid tumors. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2133/vinca-alkaloid-compounds-market0 Comentários 0 Compartilhamentos 37 Visualizações 0 Anterior - Bioresorbable Ear Packing Market Size to Reach USD 106 Million by 2032
According to a newly published market research report by 24LifeSciences, global bioresorbable ear packing market was valued at USD 84.5 million in 2024 and is projected to reach USD 106 million by 2031, growing at a compound annual growth rate (CAGR) of 3.4% during the forecast period.
Bioresorbable ear packing, clinically designed to aid in wound healing after middle ear surgery, helps separate mucosal surfaces, control minimal bleeding, and provide structural support during the healing process. Unlike traditional non-absorbable materials, these specialized packing solutions eliminate the need for a second surgical procedure for removal as they naturally dissolve within the body over time.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5474/bioresorbable-ear-packing-marketBioresorbable Ear Packing Market Size to Reach USD 106 Million by 2032 According to a newly published market research report by 24LifeSciences, global bioresorbable ear packing market was valued at USD 84.5 million in 2024 and is projected to reach USD 106 million by 2031, growing at a compound annual growth rate (CAGR) of 3.4% during the forecast period. Bioresorbable ear packing, clinically designed to aid in wound healing after middle ear surgery, helps separate mucosal surfaces, control minimal bleeding, and provide structural support during the healing process. Unlike traditional non-absorbable materials, these specialized packing solutions eliminate the need for a second surgical procedure for removal as they naturally dissolve within the body over time. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5474/bioresorbable-ear-packing-market0 Comentários 0 Compartilhamentos 35 Visualizações 0 Anterior - 0 Comentários 0 Compartilhamentos 4 Visualizações 0 Anterior
Mais stories